References
- Castagnola E, Rossi MR, Cesaro S, et al. Incidence of bacteremias and invasive mycoses in children with acute non-lymphoblastic leukemia: results from a multi-center Italian study. Pediatr Blood Cancer 2010;5:1103–1107.
- Leikin S, Miller D, Sather H, et al. Immunologic evaluation in the prognosis of acute lymphoblastic leukemia. A report from Childrens Cancer Study Group. Blood 1981;8:501–508.
- Sharawat SK, Gupta R, Raina V, et al. Increased coexpression of c-KIT and FLT3 receptors on myeloblasts: independent predictor of poor outcome in pediatric acute myeloid leukemia. Cytometry B Clin Cytom 2013;84:390–397.
- Feikin DR, Elie CM, Goetz MB, et al. Specificity of the antibody response to the pneumococcal polysaccharide and conjugate vaccines in human immunodeficiency virus-infected adults. Clin Diagn Lab Immunol 2004;11:137–141.
- Jolliff CR, Cost KM, Stivrins PC, et al. Reference intervals for serum IgG, IgA, IgM, C3, and C4 as determined by rate nephelometry. Clin Chem 1982;28:126–128.
- Aarli JA. Changes in serum immunoglobulin levels during phenytoin treatment of epilepsy. Acta Neurol Scand 1976;54: 423–430.
- Aarli JA. Phenytoin-induced depression of salivary IgA and gingival hyperplasia. Epilepsia 1976;17:283–291.
- Alsabti EA. Serum immunoglobulins in acute myelogenous leukemia. Neoplasma 1979;26:611–615.
- Eyrich M, Wiegering V, Lim A, et al. Immune function in children under chemotherapy for standard risk acute lymphoblastic leukaemia – a prospective study of 20 paediatric patients.Br J Haematol 2009;147:360–370.
- Hann IM, Jones PH, Evans DI, et al. Low IgG or IgA: a further indicator of poor prognosis in childhood acute lymphoblastic leukaemia. Br J Cancer 1980;41:317–319.